PharmaTher Holdings Ltd. (PHRM.CN)
CAD 0.23
(2.22%)
CAD 0.23
(2.22%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.04 CAD | 51.51% |
| 2022 | -0.07 CAD | -47.37% |
| 2021 | -0.05 CAD | -219.61% |
| 2020 | 0.04 CAD | 6000.0% |
| 2019 | -0.00 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.00 CAD | -4.88% |
| 2023 Q2 | -0.01 CAD | 20.53% |
| 2023 Q4 | -0.00 CAD | 0.0% |
| 2023 Q3 | -0.00 CAD | 65.83% |
| 2023 Q1 | -0.02 CAD | 16.57% |
| 2022 Q3 | -0.01 CAD | 66.8% |
| 2022 FY | - CAD | -47.37% |
| 2022 Q4 | -0.02 CAD | -110.47% |
| 2022 Q2 | -0.03 CAD | -27.59% |
| 2022 Q1 | -0.02 CAD | -3000.0% |
| 2021 Q4 | 0.00 CAD | 102.01% |
| 2021 FY | - CAD | -219.61% |
| 2021 Q3 | -0.03 CAD | -1947.06% |
| 2021 Q2 | -0.00 CAD | 87.22% |
| 2021 Q1 | -0.01 CAD | -1577.78% |
| 2020 Q2 | -0.02 CAD | -22.07% |
| 2020 Q3 | 0.07 CAD | 495.48% |
| 2020 Q1 | -0.01 CAD | 0.0% |
| 2020 FY | - CAD | 6000.0% |
| 2020 Q4 | 0.00 CAD | -98.71% |
| 2019 FY | - CAD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | -0.45 CAD | 92.156% |
| Asep Medical Holdings Inc | -0.13 CAD | 72.846% |
| BetterLife Pharma Inc. | -0.03 CAD | -33.712% |
| BioVaxys Technology Corp. | -0.06 CAD | 38.394% |
| ChitogenX Inc. | -0.02 CAD | -65.728% |
| Rapid Dose Therapeutics Corp. | -0.04 CAD | 13.902% |
| Defence Therapeutics Inc. | -0.30 CAD | 88.233% |
| Entheon Biomedical Corp. | -0.05 CAD | 30.512% |
| Gemina Laboratories Ltd. | -0.07 CAD | 50.972% |
| Glow Lifetech Corp. | -0.03 CAD | -22.569% |
| Lexston Life Sciences Corp. | -0.02 CAD | -53.478% |
| Pharmala Biotech Holdings Inc. | -0.01 CAD | -283.696% |
| Doseology Sciences Inc. | -0.08 CAD | 55.709% |
| MYND Life Sciences Inc. | -0.03 CAD | -9.969% |
| Nova Mentis Life Science Corp. | -0.01 CAD | -325.301% |
| PreveCeutical Medical Inc. | -0.00 CAD | -1370.833% |
| Telescope Innovations Corp. | -0.12 CAD | 70.583% |